Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

about

Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates

P2860

Q42319260-6994FC19-FEA0-4C30-AEDA-01F93AD4391C

P2860

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

Item

http://www.wikidata.org/entity/Q36829233

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

@en

type

Item

label

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

@en

prefLabel

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

@en

P1476

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy

@en

P2093

Davoud Ahmadvand

http://www.w3.org/2001/XMLSchema#string

Fatemeh Rahbarizadeh

http://www.w3.org/2001/XMLSchema#string

P2860

Improving the efficacy of antibody-based cancer therapies

Naturally occurring antibodies devoid of light chains

Nanobodies as novel agents for cancer therapy.

Efficient cancer therapy with a nanobody-based conjugate.

Biological targeting and innovative therapeutic interventions with phage-displayed peptides and structured nucleic acids (aptamers).

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.

Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells.

Genetically engineered T cells bearing chimeric nanoconstructed receptors harboring TAG-72-specific camelid single domain antibodies as targeting agents.

Biology of HER2 and its importance in breast cancer.

Development of anti-p185HER2 immunoliposomes for cancer therapy

P304

1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.5681/BI.2013.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Seyed Moein Moghimi

Ladan Parhamifar

P577

2013-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236913081

http://www.w3.org/2001/XMLSchema#string

P698

23678463

http://www.w3.org/2001/XMLSchema#string

P932

3648910

http://www.w3.org/2001/XMLSchema#string

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

about

P2860

P2860

Heavy Chain Only Antibodies: A New Paradigm in Personalized HER2+ Breast Cancer Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932